Summary
For Year 2026-27, Tatva Chintan Pharma Chem reports the following shareholding: Total Promoters at 72.02%, Mutual Fund at 2.87%, Insurance at 0%, Foreign Institutional Investors at 3.81%, Domestic Institutional Investors at 0.13%, and Retail at 21.17%. This breakdown provides a quick snapshot of ownership distribution for Tatva Chintan Pharma Chem in 2026-27.
Tatva Chintan Pharma Chem FAQs
As of 05-2026, the promoter shareholding in Tatva Chintan Pharma Chem stands at 72.02% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Tatva Chintan Pharma Chem is 3.81% and 0.13% respectively.
The retail shareholding of the Tatva Chintan Pharma Chem is 21.17%.
Changes in shareholding patterns of Tatva Chintan Pharma Chem can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Tatva Chintan Pharma Chem are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Tatva Chintan Pharma Chem Associated Pages
- Tatva Chintan Pharma Chem Share Price
- Tatva Chintan Pharma Chem Share Price chart
- Tatva Chintan Pharma Chem Fundamental Analysis
- Tatva Chintan Pharma Chem Technical Analysis
- Tatva Chintan Pharma Chem Peer Comparison
- Tatva Chintan Pharma Chem Share Price History
- Tatva Chintan Pharma Chem Dividend
- Tatva Chintan Pharma Chem Board of Directors
